The findings showed that P2Y12 inhibitors were more effective than aspirin in reducing the risk of heart attacks and strokes.
P2Y12 receptor antagonists (clopidogrel, prasugrel, ticagrelor (Brilinta, AstraZeneca) and ticlopidine) are indicated in all STEMI cases unless urgent surgery is required. Clopidogrel can also be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback